Prophage integration into CRISPR loci enables evasion of antiviral immunity in Streptococcus pyogenes

Andrew Varble,Edmondo Campisi,Chad W. Euler,Pascal Maguin,Albina Kozlova,Jessica Fyodorova,Jakob T. Rostøl,Vincent A. Fischetti,Luciano A. Marraffini

DOI: https://doi.org/10.1038/s41564-021-00996-8

IF: 28.3

2021-11-24

Nature Microbiology

Abstract:CRISPR loci are composed of short DNA repeats separated by sequences, known as spacers, that match the genomes of invaders such as phages and plasmids. Spacers are transcribed and processed to generate RNA guides used by CRISPR-associated nucleases to recognize and destroy the complementary nucleic acids of invaders. To counteract this defence, phages can produce small proteins that inhibit these nucleases, termed anti-CRISPRs (Acrs). Here we demonstrate that the ΦAP1.1 temperate phage utilizes an alternative approach to antagonize the type II-A CRISPR response in Streptococcus pyogenes. Immediately after infection, this phage expresses a small anti-CRISPR protein, AcrIIA23, that prevents Cas9 function, allowing ΦAP1.1 to integrate into the direct repeats of the CRISPR locus, neutralizing immunity. However, acrIIA23 is not transcribed during lysogeny and phage integration/excision cycles can result in the deletion and/or transduction of spacers, enabling a complex modulation of the type II-A CRISPR immune response. A bioinformatic search identified prophages integrated not only in the CRISPR repeats, but also the cas genes, of diverse bacterial species, suggesting that prophage disruption of the CRISPR–cas locus is a recurrent mechanism to counteract immunity.

microbiology